State Public Health Agency
Nashville, TN
USA
Email: marion.kainer@tn.gov
					
					
					
					Papers:
					107 
					Pilot Evaluation of a Simplified Point Prevalence Survey of Antimicrobial Use in Acute Care Facilities 
		
					110 
					Impact of Monthly Data Quality Checks for Facilities on Surgical Site Infection (SSI) Data 
		
					112 
					Dialysis Event Reporting and Prevention Efforts in Tennessee 
		
					123 
					Initial Assessment of Antimicrobial Stewardship Capacity in Tennessee Acute Care Hospitals 
		
					140 
					A Retrospective Assessment of Appropriate Antimicrobial Use Among Acute Care Inpatients at Three Tennessee Hospitals 
		
					200 
					Surveillance Evaluation of Methicillin-Resistant Staphylococcus Aureus Reporting through the National Electronic Disease Surveillance System Base System in Tennessee 
		
					 
					Collaboration Between Public Health and the State Board of Pharmacy and Its Inspectors to Promote Safe Sterile Compounding 
		
					 
					Investigation of a Cluster of Methicillin-Sensitive Staphylococcus Aureus Infections Among Patients Who Received Joint Injections in a Tennessee Outpatient Clinic 
		
					 
					Expanded Surveillance in the Acute Care Setting in an Investigation of an Outbreak of Serratia Liquefaciens Bloodstream Infections at an Outpatient Hemodialysis Facility 
		
					 
					Estimating Population-Based Incidence Measures of Methicillin-Resistant Staphylococcus Aureus Using the National Healthcare Safety Network and the Tennessee Joint Annual Report of Hospitals 
		
					 
					Identifying Possible Bloodstream Infection Outbreaks Among Dialysis Facilities in Tennessee Using the National Healthcare Safety Network and Whonet 
		
					 
					Targeting Intervention for Healthcare-Associated Infections in Tennessee: Methods for Identifying and Communicating Facility-Specific Impact on Statewide Standardized Infection Ratios 
		
					 
					Outbreak Data Management for Novel Coronavirus Using Redcap 
		
					 
					Improving Information Exchange with the Food and Drug Administration Regarding Contaminated Medications